Marinomed Biotech receives US Patent approval for the Marinosolv® technology and invests in a series of new patents
Press release
Marinomed Biotech AG reports increase in revenues for the first 9 months 2022 and significant business development progress
Press release
First successful year on the market for Marinomed’s Solv4U technology partnerships
Press release
Marinomed to attend several upcoming investor and industry conferences
Press release
Lucia Mayr-Harting, MSc
Public Relations